Carl Anderson
Advertisement
Articles by Carl Anderson
Shedding light on common EMR concerns about privacy, government regulations, and data integrity.
Carl Anderson, senior consultant for Biologics Consulting Group, addresses the frequent overuse of Notes to File and concludes that documenting a mistake means absolutely nothing during an FDA inspection.
Advertisement
Latest Updated Articles
Key Updates to the 1572Published: May 23rd 2012 | Updated:
Note to File (NTF) is Not an FDA PanaceaPublished: March 1st 2008 | Updated:
The Ins and Outs of Electronic Medical RecordsPublished: September 1st 2008 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
How the FDA’s CNPV Program Is Reshaping Trial Operations and Accelerated Review Strategies
2
Former FDA Commissioners Warn New Vaccine Policies Could Undermine Longstanding Regulatory Framework
3
Voyxact Lands FDA Accelerated Approval Following Positive Results in Phase III VISIONARY Trial
4
Obesity Trials: Scaling Operations for High-Demand Therapeutics
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
